The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Cisplatin is one of the most commonly used drugs in current combined chemotherapy. Its chemical name is cis-dichlorodiaminoplatin, which is an inorganic metal complex. After chlorine dissociation, it cross-connects with the DNA of cancer cells, thus damaging the function of DNA.It may form intracyclic Chemicalbook or cross-linking with DNA, or it may form cross-linking with DNA and proteins, and inhibit cell mitosis. It is a non-specific drug in cell cycle, which can inhibit lymphocyte transformation in addition to anticancer, has immunosuppressive effect, and can be used as metal complexes for anticancer drugs.
The global Cisplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cisplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cisplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cisplatin in Testicular Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cisplatin include Eli Lilly and Company, Hospira, Pfizer, Bedford Pharmaceuticals, Alvogen, Athenex Pharmaceutical, Gland Pharma (Fosun Pharma), West-Ward Pharmaceuticals and WG Critical Care, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cisplatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cisplatin.
Report Scope
The Cisplatin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cisplatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cisplatin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Hospira
Pfizer
Bedford Pharmaceuticals
Alvogen
Athenex Pharmaceutical
Gland Pharma (Fosun Pharma)
West-Ward Pharmaceuticals
WG Critical Care
David Bull Laboratories
Omega Laboratories
Fresenius Kabi
TEVA
Mylan Pharmaceuticals
Yunnan Plant Pharmaceutical
Yunnan Biological Valley Pharmaceutical
Dezhou de Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Qilu Pharmaceutical
Segment by Type
Tablets
Injection
Segment by Application
Testicular Cancer
Osteosarcoma
Breast Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cisplatin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cisplatin is one of the most commonly used drugs in current combined chemotherapy. Its chemical name is cis-dichlorodiaminoplatin, which is an inorganic metal complex. After chlorine dissociation, it cross-connects with the DNA of cancer cells, thus damaging the function of DNA.It may form intracyclic Chemicalbook or cross-linking with DNA, or it may form cross-linking with DNA and proteins, and inhibit cell mitosis. It is a non-specific drug in cell cycle, which can inhibit lymphocyte transformation in addition to anticancer, has immunosuppressive effect, and can be used as metal complexes for anticancer drugs.
The global Cisplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cisplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cisplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cisplatin in Testicular Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cisplatin include Eli Lilly and Company, Hospira, Pfizer, Bedford Pharmaceuticals, Alvogen, Athenex Pharmaceutical, Gland Pharma (Fosun Pharma), West-Ward Pharmaceuticals and WG Critical Care, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cisplatin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cisplatin.
Report Scope
The Cisplatin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cisplatin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cisplatin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Hospira
Pfizer
Bedford Pharmaceuticals
Alvogen
Athenex Pharmaceutical
Gland Pharma (Fosun Pharma)
West-Ward Pharmaceuticals
WG Critical Care
David Bull Laboratories
Omega Laboratories
Fresenius Kabi
TEVA
Mylan Pharmaceuticals
Yunnan Plant Pharmaceutical
Yunnan Biological Valley Pharmaceutical
Dezhou de Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Qilu Pharmaceutical
Segment by Type
Tablets
Injection
Segment by Application
Testicular Cancer
Osteosarcoma
Breast Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cisplatin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cisplatin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablets
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Cisplatin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Testicular Cancer
1.3.3 Osteosarcoma
1.3.4 Breast Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cisplatin Market Perspective (2019-2030)
2.2 Cisplatin Growth Trends by Region
2.2.1 Global Cisplatin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cisplatin Historic Market Size by Region (2019-2024)
2.2.3 Cisplatin Forecasted Market Size by Region (2025-2030)
2.3 Cisplatin Market Dynamics
2.3.1 Cisplatin Industry Trends
2.3.2 Cisplatin Market Drivers
2.3.3 Cisplatin Market Challenges
2.3.4 Cisplatin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cisplatin Players by Revenue
3.1.1 Global Top Cisplatin Players by Revenue (2019-2024)
3.1.2 Global Cisplatin Revenue Market Share by Players (2019-2024)
3.2 Global Cisplatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cisplatin Revenue
3.4 Global Cisplatin Market Concentration Ratio
3.4.1 Global Cisplatin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cisplatin Revenue in 2023
3.5 Cisplatin Key Players Head office and Area Served
3.6 Key Players Cisplatin Product Solution and Service
3.7 Date of Enter into Cisplatin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cisplatin Breakdown Data by Type
4.1 Global Cisplatin Historic Market Size by Type (2019-2024)
4.2 Global Cisplatin Forecasted Market Size by Type (2025-2030)
5 Cisplatin Breakdown Data by Application
5.1 Global Cisplatin Historic Market Size by Application (2019-2024)
5.2 Global Cisplatin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cisplatin Market Size (2019-2030)
6.2 North America Cisplatin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cisplatin Market Size by Country (2019-2024)
6.4 North America Cisplatin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cisplatin Market Size (2019-2030)
7.2 Europe Cisplatin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cisplatin Market Size by Country (2019-2024)
7.4 Europe Cisplatin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cisplatin Market Size (2019-2030)
8.2 Asia-Pacific Cisplatin Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cisplatin Market Size by Region (2019-2024)
8.4 Asia-Pacific Cisplatin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cisplatin Market Size (2019-2030)
9.2 Latin America Cisplatin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cisplatin Market Size by Country (2019-2024)
9.4 Latin America Cisplatin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cisplatin Market Size (2019-2030)
10.2 Middle East & Africa Cisplatin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cisplatin Market Size by Country (2019-2024)
10.4 Middle East & Africa Cisplatin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Cisplatin Introduction
11.1.4 Eli Lilly and Company Revenue in Cisplatin Business (2019-2024)
11.1.5 Eli Lilly and Company Recent Development
11.2 Hospira
11.2.1 Hospira Company Detail
11.2.2 Hospira Business Overview
11.2.3 Hospira Cisplatin Introduction
11.2.4 Hospira Revenue in Cisplatin Business (2019-2024)
11.2.5 Hospira Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cisplatin Introduction
11.3.4 Pfizer Revenue in Cisplatin Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Bedford Pharmaceuticals
11.4.1 Bedford Pharmaceuticals Company Detail
11.4.2 Bedford Pharmaceuticals Business Overview
11.4.3 Bedford Pharmaceuticals Cisplatin Introduction
11.4.4 Bedford Pharmaceuticals Revenue in Cisplatin Business (2019-2024)
11.4.5 Bedford Pharmaceuticals Recent Development
11.5 Alvogen
11.5.1 Alvogen Company Detail
11.5.2 Alvogen Business Overview
11.5.3 Alvogen Cisplatin Introduction
11.5.4 Alvogen Revenue in Cisplatin Business (2019-2024)
11.5.5 Alvogen Recent Development
11.6 Athenex Pharmaceutical
11.6.1 Athenex Pharmaceutical Company Detail
11.6.2 Athenex Pharmaceutical Business Overview
11.6.3 Athenex Pharmaceutical Cisplatin Introduction
11.6.4 Athenex Pharmaceutical Revenue in Cisplatin Business (2019-2024)
11.6.5 Athenex Pharmaceutical Recent Development
11.7 Gland Pharma (Fosun Pharma)
11.7.1 Gland Pharma (Fosun Pharma) Company Detail
11.7.2 Gland Pharma (Fosun Pharma) Business Overview
11.7.3 Gland Pharma (Fosun Pharma) Cisplatin Introduction
11.7.4 Gland Pharma (Fosun Pharma) Revenue in Cisplatin Business (2019-2024)
11.7.5 Gland Pharma (Fosun Pharma) Recent Development
11.8 West-Ward Pharmaceuticals
11.8.1 West-Ward Pharmaceuticals Company Detail
11.8.2 West-Ward Pharmaceuticals Business Overview
11.8.3 West-Ward Pharmaceuticals Cisplatin Introduction
11.8.4 West-Ward Pharmaceuticals Revenue in Cisplatin Business (2019-2024)
11.8.5 West-Ward Pharmaceuticals Recent Development
11.9 WG Critical Care
11.9.1 WG Critical Care Company Detail
11.9.2 WG Critical Care Business Overview
11.9.3 WG Critical Care Cisplatin Introduction
11.9.4 WG Critical Care Revenue in Cisplatin Business (2019-2024)
11.9.5 WG Critical Care Recent Development
11.10 David Bull Laboratories
11.10.1 David Bull Laboratories Company Detail
11.10.2 David Bull Laboratories Business Overview
11.10.3 David Bull Laboratories Cisplatin Introduction
11.10.4 David Bull Laboratories Revenue in Cisplatin Business (2019-2024)
11.10.5 David Bull Laboratories Recent Development
11.11 Omega Laboratories
11.11.1 Omega Laboratories Company Detail
11.11.2 Omega Laboratories Business Overview
11.11.3 Omega Laboratories Cisplatin Introduction
11.11.4 Omega Laboratories Revenue in Cisplatin Business (2019-2024)
11.11.5 Omega Laboratories Recent Development
11.12 Fresenius Kabi
11.12.1 Fresenius Kabi Company Detail
11.12.2 Fresenius Kabi Business Overview
11.12.3 Fresenius Kabi Cisplatin Introduction
11.12.4 Fresenius Kabi Revenue in Cisplatin Business (2019-2024)
11.12.5 Fresenius Kabi Recent Development
11.13 TEVA
11.13.1 TEVA Company Detail
11.13.2 TEVA Business Overview
11.13.3 TEVA Cisplatin Introduction
11.13.4 TEVA Revenue in Cisplatin Business (2019-2024)
11.13.5 TEVA Recent Development
11.14 Mylan Pharmaceuticals
11.14.1 Mylan Pharmaceuticals Company Detail
11.14.2 Mylan Pharmaceuticals Business Overview
11.14.3 Mylan Pharmaceuticals Cisplatin Introduction
11.14.4 Mylan Pharmaceuticals Revenue in Cisplatin Business (2019-2024)
11.14.5 Mylan Pharmaceuticals Recent Development
11.15 Yunnan Plant Pharmaceutical
11.15.1 Yunnan Plant Pharmaceutical Company Detail
11.15.2 Yunnan Plant Pharmaceutical Business Overview
11.15.3 Yunnan Plant Pharmaceutical Cisplatin Introduction
11.15.4 Yunnan Plant Pharmaceutical Revenue in Cisplatin Business (2019-2024)
11.15.5 Yunnan Plant Pharmaceutical Recent Development
11.16 Yunnan Biological Valley Pharmaceutical
11.16.1 Yunnan Biological Valley Pharmaceutical Company Detail
11.16.2 Yunnan Biological Valley Pharmaceutical Business Overview
11.16.3 Yunnan Biological Valley Pharmaceutical Cisplatin Introduction
11.16.4 Yunnan Biological Valley Pharmaceutical Revenue in Cisplatin Business (2019-2024)
11.16.5 Yunnan Biological Valley Pharmaceutical Recent Development
11.17 Dezhou de Pharmaceutical
11.17.1 Dezhou de Pharmaceutical Company Detail
11.17.2 Dezhou de Pharmaceutical Business Overview
11.17.3 Dezhou de Pharmaceutical Cisplatin Introduction
11.17.4 Dezhou de Pharmaceutical Revenue in Cisplatin Business (2019-2024)
11.17.5 Dezhou de Pharmaceutical Recent Development
11.18 Jiangsu Haosen Pharmaceutical Group
11.18.1 Jiangsu Haosen Pharmaceutical Group Company Detail
11.18.2 Jiangsu Haosen Pharmaceutical Group Business Overview
11.18.3 Jiangsu Haosen Pharmaceutical Group Cisplatin Introduction
11.18.4 Jiangsu Haosen Pharmaceutical Group Revenue in Cisplatin Business (2019-2024)
11.18.5 Jiangsu Haosen Pharmaceutical Group Recent Development
11.19 Qilu Pharmaceutical
11.19.1 Qilu Pharmaceutical Company Detail
11.19.2 Qilu Pharmaceutical Business Overview
11.19.3 Qilu Pharmaceutical Cisplatin Introduction
11.19.4 Qilu Pharmaceutical Revenue in Cisplatin Business (2019-2024)
11.19.5 Qilu Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Cisplatin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tablets
Table 3. Key Players of Injection
Table 4. Global Cisplatin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Cisplatin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cisplatin Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Cisplatin Market Share by Region (2019-2024)
Table 8. Global Cisplatin Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Cisplatin Market Share by Region (2025-2030)
Table 10. Cisplatin Market Trends
Table 11. Cisplatin Market Drivers
Table 12. Cisplatin Market Challenges
Table 13. Cisplatin Market Restraints
Table 14. Global Cisplatin Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Cisplatin Market Share by Players (2019-2024)
Table 16. Global Top Cisplatin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cisplatin as of 2023)
Table 17. Ranking of Global Top Cisplatin Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Cisplatin Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cisplatin Product Solution and Service
Table 21. Date of Enter into Cisplatin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cisplatin Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Cisplatin Revenue Market Share by Type (2019-2024)
Table 25. Global Cisplatin Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Cisplatin Revenue Market Share by Type (2025-2030)
Table 27. Global Cisplatin Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Cisplatin Revenue Market Share by Application (2019-2024)
Table 29. Global Cisplatin Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Cisplatin Revenue Market Share by Application (2025-2030)
Table 31. North America Cisplatin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Cisplatin Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Cisplatin Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Cisplatin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Cisplatin Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Cisplatin Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Cisplatin Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Cisplatin Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Cisplatin Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cisplatin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Cisplatin Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Cisplatin Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Cisplatin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Cisplatin Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Cisplatin Market Size by Country (2025-2030) & (US$ Million)
Table 46. Eli Lilly and Company Company Detail
Table 47. Eli Lilly and Company Business Overview
Table 48. Eli Lilly and Company Cisplatin Product
Table 49. Eli Lilly and Company Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 50. Eli Lilly and Company Recent Development
Table 51. Hospira Company Detail
Table 52. Hospira Business Overview
Table 53. Hospira Cisplatin Product
Table 54. Hospira Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 55. Hospira Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Cisplatin Product
Table 59. Pfizer Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Bedford Pharmaceuticals Company Detail
Table 62. Bedford Pharmaceuticals Business Overview
Table 63. Bedford Pharmaceuticals Cisplatin Product
Table 64. Bedford Pharmaceuticals Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 65. Bedford Pharmaceuticals Recent Development
Table 66. Alvogen Company Detail
Table 67. Alvogen Business Overview
Table 68. Alvogen Cisplatin Product
Table 69. Alvogen Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 70. Alvogen Recent Development
Table 71. Athenex Pharmaceutical Company Detail
Table 72. Athenex Pharmaceutical Business Overview
Table 73. Athenex Pharmaceutical Cisplatin Product
Table 74. Athenex Pharmaceutical Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 75. Athenex Pharmaceutical Recent Development
Table 76. Gland Pharma (Fosun Pharma) Company Detail
Table 77. Gland Pharma (Fosun Pharma) Business Overview
Table 78. Gland Pharma (Fosun Pharma) Cisplatin Product
Table 79. Gland Pharma (Fosun Pharma) Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 80. Gland Pharma (Fosun Pharma) Recent Development
Table 81. West-Ward Pharmaceuticals Company Detail
Table 82. West-Ward Pharmaceuticals Business Overview
Table 83. West-Ward Pharmaceuticals Cisplatin Product
Table 84. West-Ward Pharmaceuticals Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 85. West-Ward Pharmaceuticals Recent Development
Table 86. WG Critical Care Company Detail
Table 87. WG Critical Care Business Overview
Table 88. WG Critical Care Cisplatin Product
Table 89. WG Critical Care Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 90. WG Critical Care Recent Development
Table 91. David Bull Laboratories Company Detail
Table 92. David Bull Laboratories Business Overview
Table 93. David Bull Laboratories Cisplatin Product
Table 94. David Bull Laboratories Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 95. David Bull Laboratories Recent Development
Table 96. Omega Laboratories Company Detail
Table 97. Omega Laboratories Business Overview
Table 98. Omega Laboratories Cisplatin Product
Table 99. Omega Laboratories Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 100. Omega Laboratories Recent Development
Table 101. Fresenius Kabi Company Detail
Table 102. Fresenius Kabi Business Overview
Table 103. Fresenius Kabi Cisplatin Product
Table 104. Fresenius Kabi Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 105. Fresenius Kabi Recent Development
Table 106. TEVA Company Detail
Table 107. TEVA Business Overview
Table 108. TEVA Cisplatin Product
Table 109. TEVA Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 110. TEVA Recent Development
Table 111. Mylan Pharmaceuticals Company Detail
Table 112. Mylan Pharmaceuticals Business Overview
Table 113. Mylan Pharmaceuticals Cisplatin Product
Table 114. Mylan Pharmaceuticals Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 115. Mylan Pharmaceuticals Recent Development
Table 116. Yunnan Plant Pharmaceutical Company Detail
Table 117. Yunnan Plant Pharmaceutical Business Overview
Table 118. Yunnan Plant Pharmaceutical Cisplatin Product
Table 119. Yunnan Plant Pharmaceutical Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 120. Yunnan Plant Pharmaceutical Recent Development
Table 121. Yunnan Biological Valley Pharmaceutical Company Detail
Table 122. Yunnan Biological Valley Pharmaceutical Business Overview
Table 123. Yunnan Biological Valley Pharmaceutical Cisplatin Product
Table 124. Yunnan Biological Valley Pharmaceutical Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 125. Yunnan Biological Valley Pharmaceutical Recent Development
Table 126. Dezhou de Pharmaceutical Company Detail
Table 127. Dezhou de Pharmaceutical Business Overview
Table 128. Dezhou de Pharmaceutical Cisplatin Product
Table 129. Dezhou de Pharmaceutical Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 130. Dezhou de Pharmaceutical Recent Development
Table 131. Jiangsu Haosen Pharmaceutical Group Company Detail
Table 132. Jiangsu Haosen Pharmaceutical Group Business Overview
Table 133. Jiangsu Haosen Pharmaceutical Group Cisplatin Product
Table 134. Jiangsu Haosen Pharmaceutical Group Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 135. Jiangsu Haosen Pharmaceutical Group Recent Development
Table 136. Qilu Pharmaceutical Company Detail
Table 137. Qilu Pharmaceutical Business Overview
Table 138. Qilu Pharmaceutical Cisplatin Product
Table 139. Qilu Pharmaceutical Revenue in Cisplatin Business (2019-2024) & (US$ Million)
Table 140. Qilu Pharmaceutical Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cisplatin Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cisplatin Market Share by Type: 2023 VS 2030
Figure 3. Tablets Features
Figure 4. Injection Features
Figure 5. Global Cisplatin Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Cisplatin Market Share by Application: 2023 VS 2030
Figure 7. Testicular Cancer Case Studies
Figure 8. Osteosarcoma Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Cisplatin Report Years Considered
Figure 11. Global Cisplatin Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Cisplatin Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Cisplatin Market Share by Region: 2023 VS 2030
Figure 14. Global Cisplatin Market Share by Players in 2023
Figure 15. Global Top Cisplatin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cisplatin as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Cisplatin Revenue in 2023
Figure 17. North America Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Cisplatin Market Share by Country (2019-2030)
Figure 19. United States Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Cisplatin Market Share by Country (2019-2030)
Figure 23. Germany Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Cisplatin Market Share by Region (2019-2030)
Figure 31. China Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Cisplatin Market Share by Country (2019-2030)
Figure 39. Mexico Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Cisplatin Market Share by Country (2019-2030)
Figure 43. Turkey Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Cisplatin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Eli Lilly and Company Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 46. Hospira Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 47. Pfizer Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 48. Bedford Pharmaceuticals Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 49. Alvogen Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 50. Athenex Pharmaceutical Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 51. Gland Pharma (Fosun Pharma) Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 52. West-Ward Pharmaceuticals Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 53. WG Critical Care Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 54. David Bull Laboratories Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 55. Omega Laboratories Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 56. Fresenius Kabi Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 57. TEVA Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 58. Mylan Pharmaceuticals Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 59. Yunnan Plant Pharmaceutical Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 60. Yunnan Biological Valley Pharmaceutical Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 61. Dezhou de Pharmaceutical Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 62. Jiangsu Haosen Pharmaceutical Group Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 63. Qilu Pharmaceutical Revenue Growth Rate in Cisplatin Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
